Recurrent lymphangiomyomatosis after transplantation: Genetic analyses reveal a metastatic mechanism

American Journal of Respiratory and Critical Care Medicine

Volumn 167, Issue 7, 2003, Pages 976-982

  Karbowniczek, Magdalena ^b   Astrinidis, Aristotelis ^b   Balsara, Binaifer R ^b   Testa, Joseph R ^b   Lium, James H ^b   Colby, Thomas V ^b   McCormack, Francis X ^b   Henske, Elizabeth Petri ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b NONE

Author keywords

Hamartin; Lung transplantation; Lymphangiomyomatosis; Tuberin; Tuberous sclerosis complex

Indexed keywords

MICROSATELLITE DNA; MONOCLONAL ANTIBODY HMB 45;

ADULT; ALLOGRAFT; ANGIOMYOLIPOMA; ARTICLE; AUTOPSY; CANCER PATIENT; CASE REPORT; CELL MIGRATION; DATA ANALYSIS; DNA FINGERPRINTING; EXON; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE IDENTIFICATION; GENE MUTATION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; KIDNEY TUMOR; LUNG ALVEOLUS CELL; LUNG TRANSPLANTATION; LYMPH NODE; LYMPHANGIOMYOMA; METASTASIS; MICROSATELLITE MARKER; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; RECURRENT DISEASE; TUBEROUS SCLEROSIS COMPLEX GENE; TUMOR CELL; TUMOR SUPPRESSOR GENE; Y CHROMOSOME;

ADULT; ALLELES; BASE SEQUENCE; BIOPSY; CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, Y; DNA, NEOPLASM; EXONS; FEMALE; GENES, TUMOR SUPPRESSOR; HETEROZYGOTE; HUMANS; LOSS OF HETEROZYGOSITY; LUNG; LUNG NEOPLASMS; LUNG TRANSPLANTATION; LYMPH NODES; LYMPHANGIOLEIOMYOMATOSIS; MICROSATELLITE REPEATS; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE COMPLICATIONS; REPRESSOR PROTEINS; TREATMENT FAILURE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 0345237920     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200208-969OC     Document Type: Article

References (31)

1. Sullivan EJ. Lymphangioleiomyomatosis: a review. Chest 1998;114:1689-1703.
2. Taylor JR, Ryu J, Colby TV, Raffin TA. Lymphangioleiomyomatosis: clinical course in 32 patients. N Engl J Med 1990;323:1254-1260.
3. Avila NA, Kelly JA, Chu SC, Dwyer AJ, Moss J. Lymphangioleiomyomatosis: abdominopelvic CT and US findings. Radiology 2000;216:147-153.
4. Moss J, Avila NA, Barnes PM. Litzenberger RA, Bechtle J, Brooks PG, Hedin CJ, Hunsberger S, Kristof AS. Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex. Am J Respir Crit Care Med 2001;164:669-671.
5. Franz DN, Brody A, Meyer C, Leonard J, Chuck G, Dabora S, Sethuraman G, Colby TV, Kwiatkowski DJ, McCormack FX. Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis. Am J Respir Crit Care Med 2001;164:661-4568.
6. Costello LC, Hartman TE, Ryu JH. High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex. Mayo Clin Proc 2000;75:591-594.
7. Carsillo T, Astrinidis A, Henske EP. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci USA 2000;97:6085-6090.
8. Yu J, Astrinidis A, Henske EP. Chromosome 16 loss of heterozygosity in tuberous sclerosis and sporadic lymphangiomyomatosis. Am J Respir Crit Care Med 2001;164:1537-1540.
9. O'Brien JD, Lium JH, Parosa JF, Deyoung BR, Wick MR, Trulock EP. Lymphangiomyomatosis recurrence in the allograft after single-lung transplantation. Am J Respir Crit Care Med 1995;151:2033-2036.
10. Nine JS, Yousem SA, Paradis IL, Keenan R. Griffith BP. Lymphangioleiomyomatosis: recurrence after lung transplantation. J Heart Lung Transplant 1994;13:714-719.
11. Bittmann I, Dose TB, Muller C, Dienemann H, Vogelmeier C, Lohrs U. Lymphangioleiomyomatosis: recurrence after single lung transplantation. Hum Pathol 1997;28:1420-1423.
12. Henske EP, Scheithauer BW, Short MP, Wollmann R, Nahmias J, Hornigold N, van Slegtenhorst M, Welsh CT, Kwiatkowski DJ. Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am J Hum Genet 1996;59:400-406.
13. Au K-S, Rodriguez J, Finch J, Volcik K, Roach E, Delgado M, Rodriguez E, Northrup H. Germ-line mutational analysis of the TSC2 gene in 90 tuberous sclerosis patients. Am J Hum Genet 1997;62:286-294.
14. Boehler A, Speich R, Russi EW, Weder W. Lung transplantation for lymphangioleiomyomatosis. N Engl J Med 1996;335:1275-1280.
15. Sato T, Seyama K, Fujii H, Maruyama H, Setoguchi Y, Iwakami S, Fukuchi Y, Hino O. Mutation analysis of the TSC1 and 7TC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis. J Hum Genet 2002;47:20-28.
16. Matsui K, K Riemenschneider W, Hilbert SL, Yu ZX, Takeda K, Travis WD, Moss J, Ferrans VJ. Hyperplasia of type II pneumocytes in pulmonary lymphangioleiomyomatosis. Arch Pathol Lab Med 2000; 124:1642-1648.
17. Bittmann I, Dose T, Baretton GB, Muller C, Schwaiblmair M, Kur F, Lohrs U. Cellular chimerism of the lung after transplantation: an interphase cytogenetic study. Am J Clin Pathol 2001;115:525-533.
18. Terada N, Hamazaki T, Oka M, Hoki M, Mastalerz DM, Nakano Y, Meyer EM, Morel L, Petersen BE, Scott EW. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002;416:542-545.
19. Srivatsa B, Srivatsa S, Johnson KL, Samura O, Lee SL, Bianchi DW. Microchimerism of presumed fetal origin in thyroid specimens from women: a case-control study. Lancet 2001;358:2034-2038.
20. Quade BJ, McLachlin CM, Soto-Wright V, Zuckerman J, Mutter GL, Morton CC. Disseminated peritoneal leiomyomatosis: clonality analysis by X chromosome inactivation and cytogenetics of a clinically benign smooth muscle proliferation. Am J Pathol 1997;150:2153-2166.
21. Wienecke R, Konig A, DeClue JE. Identification of tuberin, the tuberous sclerosis-2 product: tuberin possesses specific Rap1GAP activity. J Biol Chem 1995;270:16409-16414.
22. Xiao GH, Shoarinejad F, Jin F, Golemis EA, Yeung RS. The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis. J Biol Chem 1997; 272:6097-6100.
23. Ito N, Rubin GM. Gigas, a Drosophila homolog of tuberous sclerosis gene product-2, regulates the cell cycle. Cell 1999;96:529-539.
24. Soucek T, Pusch O, Wienecke R, DeClue JE, Hengstschlager M. Role of the tuberous sclerosis gene-2 product in cell cycle control: loss of the tuberous sclerosis gene-2 induces quiescent cells to enter S phase. J Biol Chem 1997;272:29301-29308.
25. Miloloza A, Rosner M, Nellist M, Halley D. Bernaschek G, Hengstschlager M. The TSC1 gene product, hamartin, negatively regulates cell proliferation. Hum Mol Genet 2000;9:1721-1727.
26. Potter CJ, Huang H, Xu T. Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size. Cell 2001;105:357-368.
27. Tapon N, Ito N, Dickson BJ, Treisman JE, Hariharan IK. The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation. Cell 2001;105:345-355.
28. Henry KW, Yuan X, Koszewski NJ, Onda H, Kwiatkowski DJ, Noonan DJ. Tuberous sclerosis gene 2 product modulates transcription mediated by steroid hormone receptor family members. J Biol Chem 1998; 273:20535-20539.
29. Kwiatkowski DJ, Zhang H, Bandura JL, Heiberger KM, Glogauer M, el-Hashemite N, Onda H. A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p7086 kinase activity in Tsc1 null cells. Hum Mol Genet 2002;11:525-534.
30. Goncharova EA, Goncharov DA, Eszterhas A, Hunter DS, Glassberg MK, Yeung RS, Walker CL, Noonan D, Kwiatkowski DJ, Chou MM, et al. Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation: a role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM). J Biol Chem 2002;277:30958-30967.
31. Lamb RF, Roy C, Diefenbach TJ, Vinters HV, Johnson MW, Jay DG, Hall A. The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho. Nat Cell Biol 2000;2:281-287.